The downgrade is based on a number of factors, including GSH’s unexpected material declines in liquidity.
The outlook is negative, reflecting the extent of GSH’s liquidity decline and its lack of a longer track record of operating improvement.
Moody’s also assigned a “Baa3” rating to Good Samaritan Hospital’s proposed $42 million of series 2016A bonds.
More articles on healthcare finance:
How hospitals can elevate the standard of care and lower hospital costs
Fitch revises Summa Health System’s outlook to positive
6 Massachusetts health networks test ACO pilot program for Medicaid
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
